Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Schnittert

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Trends in Cancer|February 14, 2019
Targeting Pancreatic Stellate Cells in CancerJonas Schnittert, Ruchi Bansal, Jai Prakash
Advanced Drug Delivery Reviews|February 8, 2018
Integrins in wound healing, fibrosis and tumor stroma: High potential targets for therapeutics and drug deliveryJonas Schnittert, Ruchi Bansal, Gert Storm, et al.
Frontiers in Oncology|February 3, 2016
MicroRNA Targeting to Modulate Tumor MicroenvironmentPraneeth R Kuninty, Jonas Schnittert, Gert Storm, et al.
Cancer Letters|February 7, 2018
Reprogramming tumor stroma using an endogenous lipid lipoxin A4 to treat pancreatic cancerJonas Schnittert, Marcel A Heinrich, Praneeth R Kuninty, et al.
Nanomedicine (London, England)|May 20, 2017
Anti-microRNA targeting using peptide-based nanocomplexes to inhibit differentiation of human pancreatic stellate cellsJonas Schnittert, Praneeth R Kuninty, Tomasz F Bystry, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 28, 2019
Integrin α11 in pancreatic stellate cells regulates tumor stroma interaction in pancreatic cancerJonas Schnittert, Ruchi Bansal, Deby F Mardhian, et al.
British Journal of Cancer|May 20, 2017
Stroma-regulated HMGA2 is an independent prognostic marker in PDAC and AACCarina Strell, Karin Jessica Norberg, Artur Mezheyeuski, et al.
Science Advances|September 14, 2019
ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancreatic cancerPraneeth R Kuninty, Ruchi Bansal, Susanna W L De Geus, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Trends in Cancer|February 14, 2019
Targeting Pancreatic Stellate Cells in CancerJonas Schnittert, Ruchi Bansal, Jai Prakash
Advanced Drug Delivery Reviews|February 8, 2018
Integrins in wound healing, fibrosis and tumor stroma: High potential targets for therapeutics and drug deliveryJonas Schnittert, Ruchi Bansal, Gert Storm, et al.
Frontiers in Oncology|February 3, 2016
MicroRNA Targeting to Modulate Tumor MicroenvironmentPraneeth R Kuninty, Jonas Schnittert, Gert Storm, et al.
Cancer Letters|February 7, 2018
Reprogramming tumor stroma using an endogenous lipid lipoxin A4 to treat pancreatic cancerJonas Schnittert, Marcel A Heinrich, Praneeth R Kuninty, et al.
Nanomedicine (London, England)|May 20, 2017
Anti-microRNA targeting using peptide-based nanocomplexes to inhibit differentiation of human pancreatic stellate cellsJonas Schnittert, Praneeth R Kuninty, Tomasz F Bystry, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 28, 2019
Integrin α11 in pancreatic stellate cells regulates tumor stroma interaction in pancreatic cancerJonas Schnittert, Ruchi Bansal, Deby F Mardhian, et al.
British Journal of Cancer|May 20, 2017
Stroma-regulated HMGA2 is an independent prognostic marker in PDAC and AACCarina Strell, Karin Jessica Norberg, Artur Mezheyeuski, et al.
Science Advances|September 14, 2019
ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancreatic cancerPraneeth R Kuninty, Ruchi Bansal, Susanna W L De Geus, et al.
Pageof 1